CASC3 Antikörper (AA 501-600) (Biotin)

Produktnummer ABIN753780

Produktdetails anti-CASC3 Antikörper (Biotin)

Target: CASC3 (Cancer Susceptibility Candidate 3 (CASC3))

Bindungsspezifität: AA 501-600

Reaktivität: Maus

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser CASC3 Antikörper ist konjugiert mit Biotin

Applikation: Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))

Kreuzreaktivität: Maus

Homologie: Human,Rat,Cow,Horse

Aufreinigung: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human CASC3/MLN51

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: WB 1:300-5000
IHC-P 1:200-400
IHC-F 1:100-500

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C for 12 months.

Haltbarkeit: 12 months

Details zu CASC3

Target: CASC3 (Cancer Susceptibility Candidate 3 (CASC3))

Andere Bezeichnung: CASC3 (CASC3 Produkte)

Synonyme: BTZ antikoerper, MLN51 antikoerper, Btz antikoerper, Mln51 antikoerper, CASC3 antikoerper, btz antikoerper, mln51 antikoerper, StMLN51 antikoerper, barentsz antikoerper, XlMLN51 antikoerper, cancer susceptibility 3 antikoerper, cancer susceptibility candidate 3 antikoerper, protein CASC3 antikoerper, cancer susceptibility 3 S homeolog antikoerper, CASC3 antikoerper, Casc3 antikoerper, casc3 antikoerper, casc3.S antikoerper

Hintergrund:

Synonyms: Barentsz protein, Btz, Cancer susceptibility candidate gene 3 protein, Metastatic lymph node protein 51, MLN 51 protein, MLN51, Protein barentsz, Protein CASC3, Protein MLN 51, MLN51, CASC3_HUMAN.

Background: The multiprotein exon junction complex (EJC) is deposited on mRNAs upstream of exonexon junctions as a consequence of pre-mRNA splicing. In mammalian cells, this complex serves as a key modulator of spliced mRNA metabolism. MLN51 is a nucleocytoplasmic shuttling protein that is overexpressed in breast cancer. The function of MLN51 in mammals remains elusive. Its fly homolog, named barentsz, as well as the proteins mago nashi and tsunagi have been shown to be required for proper oskar mRNA localization to the posterior pole of the oocyte. Magoh and Y14, the human homologs of mago nashi and tsunagi, are core components of the exon junction complex (EJC). The EJC is assembled on spliced mRNAs and plays important roles in post-splicing events including mRNA export, nonsense-mediated mRNA decay, and translation. Human MLN51 is an RNA-binding protein present in ribonucleo-protein complexes.

Gen-ID: 22794